ZA944844B - Bicyclic tetrahydro pyrazolopyridines - Google Patents

Bicyclic tetrahydro pyrazolopyridines

Info

Publication number
ZA944844B
ZA944844B ZA944844A ZA944844A ZA944844B ZA 944844 B ZA944844 B ZA 944844B ZA 944844 A ZA944844 A ZA 944844A ZA 944844 A ZA944844 A ZA 944844A ZA 944844 B ZA944844 B ZA 944844B
Authority
ZA
South Africa
Prior art keywords
pyrazolopyridines
bicyclic
bicyclic tetrahydro
tetrahydro pyrazolopyridines
tetrahydro
Prior art date
Application number
ZA944844A
Inventor
Allen Jacob Duplantier
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA944844B publication Critical patent/ZA944844B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA944844A 1993-07-06 1994-07-05 Bicyclic tetrahydro pyrazolopyridines ZA944844B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8829293A 1993-07-06 1993-07-06

Publications (1)

Publication Number Publication Date
ZA944844B true ZA944844B (en) 1996-01-05

Family

ID=22210524

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA944844A ZA944844B (en) 1993-07-06 1994-07-05 Bicyclic tetrahydro pyrazolopyridines

Country Status (20)

Country Link
EP (1) EP0707585A1 (en)
JP (1) JP2944048B2 (en)
KR (1) KR100228949B1 (en)
CN (1) CN1048015C (en)
AU (1) AU695301B2 (en)
BR (1) BR9406946A (en)
CA (1) CA2166721C (en)
CZ (1) CZ3696A3 (en)
EG (1) EG20513A (en)
FI (1) FI943208A (en)
HU (1) HUT74170A (en)
IL (1) IL110175A (en)
MX (1) MX9405132A (en)
NO (1) NO305029B1 (en)
NZ (1) NZ266525A (en)
PL (1) PL312426A1 (en)
RU (1) RU2131876C1 (en)
TW (1) TW316904B (en)
WO (1) WO1995001980A1 (en)
ZA (1) ZA944844B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1050129C (en) * 1994-10-20 2000-03-08 美国辉瑞有限公司 Bicyclic tetrahydro pyrazolopyridines and their use as medicaments
US6004974A (en) * 1995-06-06 1999-12-21 Pfizer Inc Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-α]pyridines
AP932A (en) * 1996-08-26 2001-02-02 Pfizer Tricyclic 5,6-dihydro-9H-pyrazolo (3,4c)-1,2,4,-triazolo (4,3-a) pyridines.
BR9712005A (en) * 1996-09-04 1999-08-24 Pfizer Indazole derivatives and their uses as phosphodiesterase (pde) type IV inhibitors and production of tumor necrosis factor (tnf)
US6858616B2 (en) 1998-12-23 2005-02-22 Bristol-Myers Squibb Pharma Company Nitrogen containing heterobicycles as factor Xa inhibitors
SI1140941T1 (en) 1998-12-23 2005-04-30 Bristol-Myers Squibb Pharma Company Nitrogen containing heterobicycles as factor xa inhibitors
US6326495B2 (en) 1999-04-30 2001-12-04 Pfizer Inc. Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
DE60043318D1 (en) 1999-08-21 2010-01-14 Nycomed Gmbh Synergistic combination of pumafentrine and salmeterol
TWI243055B (en) * 2000-04-13 2005-11-11 Nippon Zoki Pharmaceutical Co Pharmaceutical composition for use in treatment of dermatitis
JP4555547B2 (en) * 2000-08-10 2010-10-06 ファイザー イタリア ソシエタ ア レスポンサビリタ リミタータ Bicyclic pyrazoles as kinase inhibitors, methods for preparing them and pharmaceutical compositions containing them
US6960595B2 (en) * 2001-03-23 2005-11-01 Bristol-Myers Squibb Pharma Company 5-6 to 5-7 Heterobicycles as factor Xa inhibitors
EP1379244A4 (en) 2001-04-18 2006-03-15 Bristol Myers Squibb Co 1,4,5,6-tetrahydropyrazolo- 3,4-c]-pyridin-7-ones as factor xa inhibitors
US6750225B2 (en) 2001-04-18 2004-06-15 Bristol-Myers Squibb Pharms Company 1,4,5,6-tetrahydropyrazolo-[3,4,-c]-pyridin-7-ones useful as factor Xa inhibitors
US7902179B2 (en) 2001-04-26 2011-03-08 Ajinomoto Co., Inc. Heterocyclic compounds
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
TWI325865B (en) 2003-02-27 2010-06-11 Palau Pharma Sa Pyrazolopyridine derivatives
US7135469B2 (en) * 2003-03-18 2006-11-14 Bristol Myers Squibb, Co. Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors
KR20050115331A (en) 2003-04-01 2005-12-07 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. Inhibitors of phosphodiesterases in infertility
US7145012B2 (en) 2003-04-23 2006-12-05 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
DE102005031580A1 (en) * 2005-07-06 2007-01-11 Aicuris Gmbh & Co. Kg Substituted sulfolanylpyrazoles and their use
PE20081889A1 (en) * 2007-03-23 2009-03-05 Smithkline Beecham Corp INDOL CARBOXAMIDES AS INHIBITORS OF IKK2
MX354786B (en) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER and OTHER DISORDERS.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9580471B2 (en) 2011-03-01 2017-02-28 Synergy Pharmaceuticals, Inc. Process of preparing guanylate cyclase C agonists
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP6606491B2 (en) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド Ultra high purity agonist of guanylate cyclase C, method for producing and using the same
JP6694385B2 (en) 2013-08-09 2020-05-13 アーデリクス，インコーポレーテッド Compounds and methods for inhibiting phosphate transport
CN110357888A (en) * 2018-04-09 2019-10-22 南京药捷安康生物科技有限公司 Heterocycle phosphodiesterase inhibitors and application thereof
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1463883A (en) * 1964-09-08 1966-07-22 Ciba Geigy Process for the preparation of bicyclic triaza-compounds
US3365459A (en) * 1964-09-08 1968-01-23 Ciba Geigy Corp Certain tetrahydro pyrazolo-pyridine and pyrazolo-piperidine derivatives
US3340269A (en) * 1964-09-08 1967-09-05 Ciba Geigy Corp 1-substituted 4-acyl-2, 3-dioxo-piperidine
US5356897A (en) * 1991-09-09 1994-10-18 Fujisawa Pharmaceutical Co., Ltd. 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines

Also Published As

Publication number Publication date
CA2166721A1 (en) 1995-01-19
AU6805794A (en) 1995-02-06
MX9405132A (en) 1995-01-31
IL110175A (en) 2000-01-31
TW316904B (en) 1997-10-01
CA2166721C (en) 1999-07-27
RU2131876C1 (en) 1999-06-20
CN1048015C (en) 2000-01-05
NO960056D0 (en) 1996-01-05
HU9503934D0 (en) 1996-03-28
FI943208A (en) 1995-01-07
PL312426A1 (en) 1996-04-29
EG20513A (en) 1999-06-30
CN1129940A (en) 1996-08-28
IL110175A0 (en) 1994-10-07
JP2944048B2 (en) 1999-08-30
WO1995001980A1 (en) 1995-01-19
NZ266525A (en) 1997-10-24
KR960703852A (en) 1996-08-31
NO960056L (en) 1996-01-05
AU695301B2 (en) 1998-08-13
EP0707585A1 (en) 1996-04-24
HUT74170A (en) 1996-11-28
NO305029B1 (en) 1999-03-22
FI943208A0 (en) 1994-07-05
JPH08507084A (en) 1996-07-30
KR100228949B1 (en) 1999-11-01
BR9406946A (en) 1996-08-06
CZ3696A3 (en) 1997-06-11

Similar Documents

Publication Publication Date Title
EG20513A (en) Bicyclic tetrahydro pyrazolopyridines
IL115667A0 (en) Bicyclic tetrahydro pyrazolopyridines
HU9403364D0 (en) Imidazopyridine
ZA939433B (en) Imidazopyridines
HU9201781D0 (en) Bicyclic repamicines
ZA949664B (en) Imidazopyridines
EP0702671A4 (en) Bicyclic fibrinogen antagonists
HU9601789D0 (en) Pyrazolopyridine adenosine antagonists
AU4123893A (en) Imidazopyridines
AU3019192A (en) Imidazopyridines
ZA943996B (en) Imidazopyridines
ZA932459B (en) Imidazopyridines
ZA942543B (en) Tetrohydro beta-carbolines
ZA937875B (en) Imidazopyridines
EP0745086A4 (en) Tricyclic spiropiperidines
ZA947314B (en) Tricyclic derivatives
ZA931368B (en) Sulphonylbenzyl-substituted imidazopyridines
HU9500007D0 (en) Tricyclic cepheme derivatives
EP0417059A3 (en) Bicyclic tetrahydroxylated pyrrolizidines
ZA94990B (en) New imidazopyridines
IL119547A0 (en) Imidazopyridine compounds
ZA942352B (en) Spiropiperidine derivatives
ZA9410409B (en) Pyrazolopyridine compound
ZA934289B (en) Imidazopyridines.
GB9116309D0 (en) Bicyclic derivatives